Standout Papers

Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger... 2016 2026 2019 2022 482
  1. Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits (2016)
    Antonius Baartscheer, Cees A. Schumacher et al. Diabetologia
  2. Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation (2017)
    Laween Uthman, Antonius Baartscheer et al. Diabetologia

Citation Impact

1 by Nobel laureates 17 from Science/Nature 64 standout
Sub-graph 1 of 21

Citing Papers

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Gliflozins in the Management of Cardiovascular Disease
2022 Standout
1 intermediate paper

Works of Antonius Baartscheer being referenced

Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients
2018
Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation
2017 Standout

Author Peers

Author CCM Molecular Biology CMN EDM Last Decade Papers Cites
Antonius Baartscheer 1868 1847 358 1163 52 3.3k
Shu‐Hsin Chen 3 188 11 17 17 358
Katherine R. Henshall 3 8 17 17 375
Francesc Muñoz‐Muñoz 2 42 2 1 31 449
Guida de Abreu 6 38 657
Shui-Xing Yu 4 213 1 5 20 339

All Works

Loading papers...

Rankless by CCL
2026